IRIS UniCatt

Martinotti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.170
NA - Nord America 4.479
AS - Asia 3.184
SA - Sud America 672
AF - Africa 77
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.350
IT - Italia 3.922
DE - Germania 1.691
SG - Singapore 1.511
CN - Cina 861
BR - Brasile 557
SE - Svezia 546
UA - Ucraina 418
FR - Francia 403
GB - Regno Unito 286
IE - Irlanda 175
NL - Olanda 162
VN - Vietnam 161
IN - India 147
ID - Indonesia 116
FI - Finlandia 115
RU - Federazione Russa 106
TR - Turchia 69
CH - Svizzera 66
CA - Canada 64
HK - Hong Kong 55
JP - Giappone 53
PL - Polonia 50
ES - Italia 45
AR - Argentina 43
MX - Messico 41
BD - Bangladesh 32
BE - Belgio 30
AU - Australia 28
RO - Romania 22
AT - Austria 21
ZA - Sudafrica 21
IR - Iran 20
IQ - Iraq 18
AL - Albania 16
CL - Cile 15
CI - Costa d'Avorio 14
EC - Ecuador 14
CZ - Repubblica Ceca 13
HU - Ungheria 13
NP - Nepal 13
MA - Marocco 12
SA - Arabia Saudita 12
IL - Israele 11
VE - Venezuela 11
CO - Colombia 10
KE - Kenya 9
KR - Corea 9
LT - Lituania 9
PE - Perù 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
MT - Malta 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
TH - Thailandia 7
UY - Uruguay 7
AM - Armenia 6
EG - Egitto 6
GR - Grecia 6
HR - Croazia 6
JO - Giordania 6
KZ - Kazakistan 6
PH - Filippine 6
PK - Pakistan 6
UZ - Uzbekistan 6
DO - Repubblica Dominicana 5
LV - Lettonia 5
MY - Malesia 5
OM - Oman 5
RS - Serbia 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
DZ - Algeria 4
KG - Kirghizistan 4
LU - Lussemburgo 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
LB - Libano 3
MC - Monaco 3
NO - Norvegia 3
PS - Palestinian Territory 3
PY - Paraguay 3
QA - Qatar 3
BG - Bulgaria 2
BZ - Belize 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NG - Nigeria 2
PA - Panama 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BH - Bahrain 1
Totale 16.599
Salva come PNG Salva come JPEG
Città #
Chandler 767
Singapore 663
Milan 481
Ashburn 412
Rome 394
Jacksonville 210
San Mateo 189
Dublin 168
Wilmington 147
Beijing 141
Nanjing 123
Jakarta 107
New York 107
Los Angeles 103
Woodbridge 97
Dearborn 83
Hefei 78
Nürnberg 76
Boston 70
Munich 70
Ann Arbor 67
Redwood City 67
The Dalles 62
Ho Chi Minh City 59
Moscow 58
Florence 57
Turin 57
Bologna 56
Lawrence 56
Houston 55
Marseille 55
Seattle 54
São Paulo 51
Naples 50
Norwalk 50
Bremen 49
Frankfurt am Main 49
Nanchang 48
Lancaster 42
Fairfield 41
Princeton 40
Hong Kong 39
Buffalo 38
Genoa 38
Hanoi 37
Catania 35
Cattolica 34
Verona 34
Bari 32
Falls Church 32
Guangzhou 31
Dallas 30
University Park 30
Brescia 29
Palermo 28
Changsha 27
Chicago 27
Mountain View 27
Paris 26
Tokyo 26
Tianjin 25
Hebei 24
Izmir 23
Boardman 22
Brussels 21
London 21
Warsaw 21
Hangzhou 20
Perugia 20
Shanghai 20
Shenyang 20
Kent 19
Pune 19
Cambridge 18
Fremont 18
Messina 17
Padova 17
Toronto 17
Chennai 16
Torino 16
Helsinki 15
Jiaxing 15
Kunming 15
Santa Clara 15
Tirana 15
Abidjan 14
Mexico City 14
Modena 14
Stockholm 14
Denver 13
Pisa 13
Atlanta 12
Belo Horizonte 12
Columbus 12
Düsseldorf 12
Philadelphia 12
Zurich 12
Augusta 11
Bergamo 11
Kish 11
Totale 6.865
Salva come PNG Salva come JPEG
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 2.863
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 624
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 521
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 411
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 381
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 305
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 298
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 243
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 240
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 234
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 185
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 185
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 176
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 169
Problematic mobile phone use in adolescence: A cross-sectional study 169
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 164
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 162
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 157
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 156
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 149
Topiramate in Alcohol Use Disorders: Review and Update. 148
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 144
Alcohol protracted withdrawal syndrome: the role of anhedonia 144
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 141
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 141
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 140
Behavioural addictions in adolescents and young adults: results from a prevalence study. 139
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 139
Suicide by pencil 139
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 138
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 138
Il trattamento della schizofrenia 137
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 132
Allostasis as a conceptual framework linking bipolar disorder and addiction 130
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 129
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 128
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 127
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 127
Aripiprazole, alcohol and substance abuse: a review 127
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 125
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 124
Dead under the bed: a case of Diogenes syndrome? 121
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 120
Gabapentin as add-on treatment for somatoform disorder: a case report 118
Enhanced BDNF serum levels in patients with severe pathological gambling 118
Amantadine in the treatment of pathological gambling: a case report 118
Oxcarbazepine in bipolar disorder: a critical review of the literature 116
Behavioural addictions in adolescents and young adults: results from a prevalence study 116
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 115
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? 115
A possible new option for migraine management: agomelatine 114
Who`s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 114
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 113
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone 112
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 112
Oxcarbazepine improves mood in patients with epilepsy. 111
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 111
Oxcarbazepine improves mood in patients with epilepsy 110
Cocaine use disorders and serum magnesium profile 110
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 110
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 109
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 109
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 107
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 106
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 105
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics 104
Alcohol drinking patterns in young people: A survey-based study 104
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 104
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 103
Enhanced BDNF serum levels in patients with severe pathological gambling 103
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 103
Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses 101
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 97
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 95
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 95
Empathy ability is impaired in alcohol-dependent patients 93
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 93
Prevalence and intensity of basic symptoms among cannabis users: an observational study 91
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 91
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 90
null 90
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients 89
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. 88
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. 87
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 86
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia 84
Efficacy and safety of pregabalin in alcohol dependence 83
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study 82
Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. 82
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. 81
Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects 77
Anhedonia and substance dependence: clinical correlates and treatment options 77
Trends in alcohol-related deaths in the EU countries in 1980-2003 76
Pregabalin for alcohol dependence: a critical review of the literature 76
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 71
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 68
‘Suicide on Italian Instagram: Insights and implications for prevention and support’ 60
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 59
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments 55
High depression symptomatology and mental pain characterize suicidal psychiatric patients 55
Totale 16.332
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021648 0 0 0 0 0 51 160 32 128 101 144 32
2021/20221.030 80 91 33 53 59 44 52 176 64 69 132 177
2022/20232.918 279 309 204 366 210 278 191 302 357 100 170 152
2023/20241.910 143 358 103 141 125 246 84 105 78 115 192 220
2024/20252.917 172 145 218 171 268 129 138 188 430 222 428 408
2025/20263.043 732 214 286 548 1.013 250 0 0 0 0 0 0
Totale 16.729